RecruitingPhase 2NCT07331155

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour[Substudy Number 03(ESCC)]

Sponsor

Nanjing Leads Biolabs Co.,Ltd

Enrollment

110 participants

Start Date

Feb 26, 2026

Study Type

INTERVENTIONAL

Conditions

Advanced Solid Tumour

Summary

An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 5-Fluorouracil injection, a drug called Capecitabine tablets, and others for people with advanced solid tumour. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLBL-024 for Injection

Intravenous infusion

DRUGCisplatin Injection

Intravenous infusion

DRUGPaclitaxel Injection

Intravenous infusion

DRUGTislelizumab Injection

Intravenous infusion

DRUG5-Fluorouracil injection

Intravenous infusion

DRUGCapecitabine tablets

Oral administration

Locations(7)

Beijing Cancer Hospital

Beijing, Beijing Municipality, China

AnYang Tumor Hospital

Anyang, Henan, China

The First Affiliated Hospital of Henan University of Science & Technology

Luoyang, Henan, China

Henan Cancer Hospital

Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Shandong Cancer Hospital

Jinan, Shandong, China

Suining Central Hospital

Suining, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07331155

Related Trials

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

NCT071115468 locations

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

NCT0678364724 locations

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

NCT073903837 locations